Fast start HIV medication during hospital stay
Part of Infections clinical trials.
This study tests a new approach to starting or restarting HIV medications quickly while you are in the hospital. The goal is to see if starting treatment during your stay helps you get connected to HIV care and manage the virus better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Currently admitted to the University of Chicago Medical Center's general medicine or hospital medicine floors
- Have HIV
- HIV viral load greater than 200 copies per milliliter
- Can speak and understand English
- Can and are willing to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a planned, supervised “treatment interruption” period for people with HIV who are very well controlled on HIV medicines. It mainly aims to understand what happens when therapy is paused and how to reduce the risk of passing HIV to others.
This trial tests whether giving two powerful HIV-fighting antibodies (called broadly neutralizing monoclonal antibodies) along with starting standard HIV medications soon after infection can help control the virus without needing daily pills. If successful, it might allow people to take a 'treatment pause' while keeping their immune system healthy.
This study looks at whether starting HIV treatment on the same day you are diagnosed helps reduce stigma and improves engagement in care. It involves interviews and surveys with patients and staff at two clinics in Peru.
This study tests a fast-start HIV treatment using doravirine, tenofovir, and lamivudine for people who were just diagnosed with HIV in the last 30 days and have never taken HIV medications before. The goal is to see if starting treatment right away is safe and effective.
This study tests a rapid-start antiretroviral therapy (ART) approach for people who inject drugs and have HIV. The goal is to see if starting HIV medicine quickly helps reduce stigma and improve health outcomes.
This trial tests whether you can safely stop your HIV medication for a while if your immune system has specific markers that might help control the virus. The goal is to see if a treatment pause could be an option for people like you.
Hear when a new HIV Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.